Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:22-25
Published online before print December 12, 2002, doi: 10.1161/01.STR.0000047123.14312.3E
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v34,p826)
Right arrow All Versions of this Article:
34/1/22    most recent
01.STR.0000047123.14312.3Ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huxley, R.R.
Right arrow Articles by Meschia, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huxley, R.R.
Right arrow Articles by Meschia, J. F.
Related Collections
Right arrow Epidemiology
Right arrow Lipids
Right arrow Peripheral vascular disease
Right arrow Genetics of cardiovascular disease
Right arrow Risk Factors for Stroke

(Stroke. 2003;34:22.)
© 2003 American Heart Association, Inc.


Original Contributions

Risk of Fatal Stroke in Patients With Treated Familial Hypercholesterolemia

A Prospective Registry Study

R.R. Huxley, DPhil; M.H. Hawkins, DPhil; S.E. Humphries, FRCPath; F. Karpe, MD H.A.W. Neil, FRCP for the Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee

From the Division Public Health and Primary Health Care, Institute of Health Sciences (R.R.H., H.A.W.N.), and Oxford Lipid Metabolism Group, Nuffield Department of Medicine (F.K.), University of Oxford, Oxford, UK; Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK (M.H.H.); and Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free and University College Medical School (S.E.H.).

Correspondence to Dr H.A.W. Neil, Division of Public Health and Primary Health Care, Institute of Health Sciences, University of Oxford, Old Road, Headington, Oxford, UK OX3 7LF. E-mail andrew.neil{at}wolfson.ox.ac.uk

Background and Purpose— Although it is recognized that in heterozygous familial hypercholesterolemia, large extracranial carotid vessels are affected by atherosclerosis, the risk of fatal stroke after treatment with cholesterol-lowering therapy remains uncertain. The goal of this study was to determine the risk of fatal stroke in patients with treated familial hypercholesterolemia.

Methods— A cohort of 1405 men and 1466 women with definite or possible heterozygous familial hypercholesterolemia was recruited from 21 outpatient lipid clinics in the United Kingdom. Patients were followed up prospectively from 1980 to 1998 for 22 992 person-years for a median duration of 7.9 years (interquartile range, 4.9 to 12.0 years). The mortality rate was calculated, and the standardized mortality ratio for men and women 20 to 79 years of age was derived from the ratio of the observed deaths to the number expected in the general population of England and Wales (standardized mortality ratio=100 for the standard population).

Results— A total of 169 deaths occurred; 9 (5.3%) were a result of stroke. The mortality rate from stroke was 0.39 per 1000 person-years (95% confidence interval, 0.18 to 0.74), and the standardized mortality ratio for fatal stroke was nonsignificantly lower than in the general population (79; 95% CI, 36 to 150).

Conclusions— The results suggest that patients with treated familial hypercholesterolemia are not at increased risk of fatal stroke. However, the possibility cannot be excluded that untreated individuals are at increased risk, which would be consistent with the evidence that familial hypercholesterolemia is a panvascular disease.

Editorial Comment

James F. Meschia, MD, Guest Editor



This article has been cited by other articles:


Home page
StrokeHome page
S. Soljanlahti, T. Autti, K. Lauerma, R. Raininko, P. Keto, H. Turtola, and A. F. Vuorio
Familial Hypercholesterolemia Patients Treated With Statins at No Increased Risk for Intracranial Vascular Lesions Despite Increased Cholesterol Burden and Extracranial Atherosclerosis
Stroke, July 1, 2005; 36(7): 1572 - 1574.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries
Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review
Am. J. Epidemiol., September 1, 2004; 160(5): 421 - 429.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. M. Hutter, M. A. Austin, and S. E. Humphries
Familial Hypercholesterolemia, Peripheral Arterial Disease, and Stroke: A HuGE Minireview
Am. J. Epidemiol., September 1, 2004; 160(5): 430 - 435.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R.R. Huxley, M.H. Hawkins, S.E. Humphries, F. Karpe, H.A.W. Neil, and J. F. Meschia
Risk of Fatal Stroke in Patients With Treated Familial Hypercholesterolemia: A Prospective Registry Study * Editorial Comment
Stroke, January 1, 2003; 34(1): 22 - 25.
[Abstract] [Full Text] [PDF]